Tests of unconditioned anxiety - Pitfalls and disappointments

Physiology and Behavior

Volumn 135, Issue , 2014, Pages 55-71

  Ennaceur, A ^a  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

Author keywords

Anxiolytics; Avoidance; Fear; GABAA; Grooming; Mice; Novelty; Preference; Rats; Rearing; Stress

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; MUSCLE RELAXANT AGENT; PSYCHOSTIMULANT AGENT;

ANXIETY; AVERSION; AVOIDANCE BEHAVIOR; BODY POSTURE; DRUG SENSITIVITY; ELEVATED PLUS MAZE TEST; ELEVATED ZERO MAZE TEST; ESCAPE BEHAVIOR; FEAR; GROOMING; HUMAN; LIGHT-DARK TEST; NONHUMAN; OPEN FIELD TEST; PERCEPTION; PREDICTIVE VALIDITY; PRIORITY JOURNAL; REARING; REVIEW; RISK ASSESSMENT; STRAIN DIFFERENCE; STRESS; THREAT; TRANQUILIZING ACTIVITY; UNCONDITIONED ANXIETY; ANIMAL; ANIMAL BEHAVIOR; CONDITIONING; DIAGNOSIS; DISEASE MODEL; EXPLORATORY BEHAVIOR; MAZE TEST; MOTOR ACTIVITY; MOUSE; PHYSIOLOGY; PSYCHOLOGY; RAT; REPRODUCIBILITY;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEAR; MAZE LEARNING; MICE; MOTOR ACTIVITY; RATS; REPRODUCIBILITY OF RESULTS;

EID: 84902440892     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2014.05.032     Document Type: Review

References (430)

1. Abeelen J.H.F. Genetics of rearing behavior in mice. Behav Genet 1970, 1:71-76.
2. Abrams J.K., Johnson P.L., Hay-Schmidt A., Mikkelsen J.D., Shekhar A., Lowry C.A. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs. Neuroscience 2005, 133:983-997.
3. Abuhamdah R.M., van Rensburg R., Lethbridge N.L., Ennaceur A., Chazot P.L. Effects of methimepip and JNJ-5207852 in Wistar rats exposed to an open-field with and without object and in Balb/c mice exposed to a radial-arm maze. Front Syst Neurosci 2012, 6:54.
4. Adamec R., Kent P., Anisman H., Shallow T., Merali Z. Neural plasticity, neuropeptides and anxiety in animals-implications for understanding and treating affective disorder following traumatic stress in humans. Neurosci Biobehav Rev 1998, 23:301-318.
5. Adamec R., Walling S., Burton P. Long-lasting, selective, anxiogenic effects of feline predator stress in mice. Physiol Behav 2004, 83:401-410.
6. Adamec R., Bartoszyk G.D., Burton P. Effects of systemic injections of Vilazodone, a selective serotonin reuptake inhibitor and serotonin 1A receptor agonist, on anxiety induced by predator stress in rats. Eur J Pharmacol 2004, 504:65-77.
7. Adamec R., Burton P., Blundell J., Murphy D.L., Holmes A. Vulnerability to mild predator stress in serotonin transporter knockout mice. Behav Brain Res 2006, 170:126-140.
8. Ader R., Friedman S.B., Grota L.J. Emotionality' and adrenal cortical function: effects of strain, tests, and the 24-hour corticosterone rhythm. Anim Behav 1967, 15:37-44.
9. Akimova E., Lanzenberger R., Kasper S. The serotonin-1A receptor in anxiety disorders. Biol Psychiatry 2009, 66:627-635.
10. Albonetti M.E., Farabollini F. Behavioural responses to a single and repeated restraint in male and female rats. Behav Process 1992, 28:97-110.
11. Albrechet-Souza L., de Carvalho M.C., Franci C.R., Brandão M.L. Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam. Horm Behav 2007, 52:267-273.
12. Alstott J., Timberlake W. Effects of rat sex differences and lighting on locomotor exploration of a circular open field with free-standing central corners and without peripheral walls. Behav Brain Res 2009, 96:214-219.
13. Amsel A., Cole K.F. Generalization of fear-motivated interference with water intake. J Exp Psychol 1953, 46:243-247.
14. Andreatini R., Bacellar L.F.S. Animal models: trait or state measure? The test-retest reliability of the elevated plus-maze and behavioral despair. Prog Neuro-Psychopharmacol Biol Psychiatry 2000, 24:549-560.
15. Andreatini R., Bacellar L.F.S. The relationship between anxiety and depression in animal models: a study using the forced swimming test and elevated plus-maze. Braz J Med Biol Res 1999, 32:1121-1126.
16. Angrini M., Leslie J.C., Shephard R.A. Effects of propranolol, buspirone, pCPA, reserpine, and chlordiazepoxide on open-field behavior. Pharmacol Biochem Behav 1998, 59:387-397.
17. Anisman H., Hayley S., Kelly O., Borowski T., Merali Z. Psychogenic, neurogenic, and systemic stressor effects on plasma corticosterone and behavior: mouse strain-dependent outcomes. Behav Neurosci 2001, 115:443-454.
18. Audet M.C., Goulet S., Doré F.Y. Repeated subchronic exposure to phencyclidine elicits excessive atypical grooming in rats. Behav Brain Res 2006, 167:103-110.
19. Aulich D. Escape versus exploratory activity: an interpretation of rats' behaviour in the open field and a light-dark preference test. Behav Processes 1976, 1:153-164.
20. Aureli F., van Schaik C.P. Post-conflict behaviour in longtailed macaques (Macaca fascicularis). Ethology 1991, 89:101-114.
21. Avgustinovich D.F., Lipina T.V., Bondar N.P., Alekseyenko O.V., Kudryavtseva N.N. Features of the genetically defined anxiety in mice. Behav Genet 2000, 30:101-109.
22. Baas J.M., Grillon C., Böcker K.B., Brack A.A., Morgan C.A., Kenemans J.L., et al. Benzodiazepines have no effect on fear-potentiated startle in humans. Psychopharmacology (Berl) 2002, 161:233-247.
23. Barlow D.H. Anxiety and its disorders: the nature and treatment of anxiety and panic 2002, Guilford Press, New York.
24. Barros H.M.T., Tannhauser S.L., Tannhauser M.A.L., Tannhauser M. The effects of GABAergic drugs on grooming behaviour in the open field. Pharmacol Toxicol 1994, 74:339-344.
25. Beach F.A., Fowler H. Effects of "situational anxiety" on sexual behavior in male rats. J Comp Physiol Psychol 1959, 52:245-248.
26. Beck A.T., Epstein N., Brown G., Steer R.A. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988, 56:893-897.
27. Belzung C., Le Pape G. Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety. Physiol Behav 1994, 56:623-628.
28. Belzung C., Le Guisquet A.M., Crestani F. Flumazenil induces benzodiazepine partial agonist-like effects in BALB/c but not C57BL/6 mice. Psychopharmacology (Berl) 2000, 148:24-32.
29. Belzung C., Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res 2001, 125:141-149.
30. Benno R., Smirnova Y., Vera S., Liggett A., Schanz N. Exaggerated responses to stress in the BTBR T+tf/J mouse: an unusual behavioral phenotype. Behav Brain Res 2009, 197:462-465.
31. Benton D., Brain P.F. Behavioural comparisons of isolated, dominant and subordinate mice. Behav Process 1979, 4:211-219.
32. Berry R.B., Werner D.F., Wang X., Jablonski M.M., Homanics G.E., Mittleman G., et al. Mice with targeted genetic reduction of GABAA receptor a1 subunits display performance differences in Morris water maze tasks. Neurobiol Learn Mem 2008, 90:580-583.
33. Berton F., Vogel E., Belzung C. Modulation of mice anxiety in response to cat odor as a consequence of predators diet. Physiol Behav 1998, 65:247-254.
34. Bisong S.A., Brown R., Osim E.E. Comparative effects of Rauwolfia vomitoria and chlorpromazine on locomotor behaviour and anxiety in mice. J Ethnopharmacol 2010, 132:334-339.
35. Blagden J.C., Craske M.G. Effects of active and passive rumination and distraction: a pilot replication with anxious mood. J Anxiety Disord 1996, 10:243-252.
36. Blanchard R.J., Blanchard D.C. Antipredator defensive behaviors in a visible burrow system. J Comp Psychol 1989, 103:70-82.
37. Blanchard R.J., Blanchard D.C., Rodgers J., Weiss S.M. The characterization and modelling of antipredator defensive behavior. Neurosci Biobehav Rev 1990, 14:463-472.
38. Blanchard R.J., Nikulina J.N., Sakai R.R., McKittrick C., McEwen B., Blanchard D.C. Behavioral and endocrine change following chronic predatory stress. Physiol Behav 1998, 63:561-569.
39. Blanchard D.C., Griebel G., Blanchard R.J. The mouse defense test battery: pharmacological and behavioral assays for anxiety and panic. Eur J Pharmacol 2003, 463:97-116.
40. Blanchard D.C., Griebel G., Pobbe R., Blanchard R.J. Risk assessment as an evolved threat detection and analysis process. Neurosci Biobehav Rev 2011, 35:991-998.
41. Blednov Y.A., Jung S., Alva H., Wallace D., Rosahl T., Whiting P.J., et al. Deletion of the alpha1 or beta2 subunit of GABAA receptors reduces actions of alcohol and other drugs. J Pharmacol Exp Ther 2003, 304:30-36.
42. Bolles R.C. Grooming behaviour in the rat. J Comp Physiol Psychol 1960, 53:306-310.
43. Borkovec T.D., Alcaine O., Behar E. Avoidance theory of worry and generalized anxiety disorder. Generalized anxiety disorder: advances in research and practice 2004, 77-108. Guilford Press, New York. R.G. Heimberg, C.L. Turk, D.S. Mennin (Eds.).
44. Borta A., Schwarting R.K. Inhibitory avoidance, pain reactivity, and plus-maze behavior in Wistar rats with high versus low rearing activity. Physiol Behav 2005, 84:387-396.
45. Bourin M. Animal models of anxiety: are they suitable for predicting drug action in humans?. Pol J Pharmacol 1997, 49:79-84.
46. Bourin M., Hascoët M. The mouse light/dark box test. Eur J Pharmacol 2003, 463:55-65.
47. Bourin M., Petit-Demoulière B., Dhonnchadha B.N., Hascöet M. Animal models of anxiety in mice. Fundam Clin Pharmacol 2007, 21:567-574.
48. Bouwknecht J.A., Paylor R. Behavioral and physiological mouse assays for anxiety: a survey in nine mouse strains. Behav Brain Res 2002, 136:489-501.
49. Bouwknecht J.A., van der Gugten J., Groenink L., Olivier B., Paylor R.E. Effects of repeated testing in two inbred strains on flesinoxan dose-response curves in three mouse models for anxiety. Eur J Pharmacol 2004, 494:35-44.
50. Bouwknecht J.A., Spiga F., Staub D.R., Hale M.W., Shekhar A., Lowry C.A. Differential effects of exposure to low-light or high-light open-field on anxiety-related behaviors; relationship to c-Fos expression in serotonergic and non-serotonergic neurons in the dorsal raphe nucleus. Brain Res Bull 2007, 72:32-43.
51. Bouwknecht J.A., Paylor R. Pitfalls in the interpretation of genetic and pharmacological effects on anxiety-like behaviour in rodents. Behav Pharmacol 2008, 19:385-402.
52. Bramley G.N., Waas J.R. Laboratory and field evaluation of predator odors as repellents for kiore (Rattus exulans) and ship rats (R. rattus). J Chem Ecol 2001, 27:1029-1047.
53. Braun A.A., Skelton M.R., Vorhees C.V., Williams M.T. Comparison of the elevated plus and elevated zero mazes in treated and untreated male Sprague-Dawley rats: effects of anxiolytic and anxiogenic agents. Pharmacol Biochem Behav 2011, 97:406-415.
54. Brimblecombe R.W. Effects of psychotropic drugs on open-field behaviour in rats. Psychopharmacologia 1963, 4:139-147.
55. Brioni J.D., O'Neill A.B., Kim D.J., Decker M.W. Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. Eur J Pharmacol 1993, 238:1-8.
56. Britton D.R., Britton K.T., Dalton D., Vale W. Effects of naloxone on anti-conflict and hyperphagic actions of diazepam. Life Sci 1981, 29:1297-1302.
57. Britton D.R., Britton K.T. A sensitive open field measure of anxiolytic drug activity. Pharmacol Biochem Behav 1981, 15:577-582.
58. Broadhurst P.L. Emotionality and the Yerkes-Dodson law. J Exp Psychol 1957, 54:345-352.
59. Brown G.R., Nemes C. The exploratory behaviour of rats in the hole-board apparatus: is head-dipping a valid measure of neophilia?. Behav Processes 2008, 78:442-448.
60. Buchanan R.W., Keefe R.S., Lieberman J.A., Barch D.M., Csernansky J.G., Goff D.C., Marder S.R. A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biol Psychiatry 2011, 69:442-449.
61. Cai W.H., Blundell J., Han J., Greene R.W., Powell C.M. Postreactivation glucocorticoids impair recall of established fear memory. J Neurosci 2006, 26:9560-9566.
62. Calatayud F., Belzung C., Aubert A. Ethological validation and the assessment of anxiety-like behaviours: methodological comparison of classical analyses and structural approaches. Behav Process 2004, 67:195-206.
63. Carli M., Prontera C., Samanin R. Effect of 5-HT1A agonists on stress-induced deficit in open field locomotor activity of rats: evidence that this model identifies anxiolytic-like activity. Neuropharmacology 1989, 28:471-476.
64. Carobrez A.P., Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20years on. Neurosci Biobehav Rev 2005, 29:1193-1205.
65. Carola V., D'Olimpio F., Brunamonti E., Mangia F., Renzi P. Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice. Behav Brain Res 2002, 134:49-57.
66. Casarrubea M., Roy V., Sorbera F., Magnusson M.S., Santangelo A., Arabo A., et al. Temporal structure of the rat's behavior in elevated plus maze test. Behav Brain Res 2013, 237:290-299.
67. Castner S.A., Arriza J.L., Roberts J.C., Mrzljak L., Christian E.P., Williams G.V. Reversal of ketamine-induced working memory impairments by the GABAAalpha2/3 agonist TPA023. Biol Psychiatry 2010, 67:998-1001.
68. Catherall D.R. How fear differs from anxiety. Traumatology 2003, 9:76-92.
69. Cattell R.B., Scheier I.M. The meaning and measurement of neuroticism and anxiety 1961, Ronald Press, New York.
70. Cattell R.B., Shrader R.R., Barton K. The definition and measurement of anxiety as a trait and a state in the 12- to 17-year range. Br J Soc Clin Psychol 1974, 13:173-182.
71. Chadman K.K. Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism. Pharmacol Biochem Behav 2011, 97:586-594.
72. Chaouloff F., Durand M., Mormède P. Anxiety- and activity-related effects of diazepam and chlordiazepoxide in the rat light/dark and dark/light tests. Behav Brain Res 1997, 85:27-35.
73. Chapillon P., Manneché C., Belzung C., Caston J. Rearing environmental enrichment in two inbred strains of mice: 1. Effects on emotional reactivity. Behav Genet 1999, 29:41-46.
74. Choleris E., Thomas A.W., Kavaliers M., Prato F.S. A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci Biobehav Rev 2001, 25:235-260.
75. Clément Y., Le Guisquet A.M., Venault P., Chapouthier G., Belzung C. Pharmacological alterations of anxious behaviour in mice depending on both strain and the behavioural situation. PLoS One 2009, 4:e7745.
76. Cole J.C., Rodgers R.J. Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze. Pharmacol Biochem Behav 1995, 52:473-478.
77. Collinson N., Dawson G.R. On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635. Psychopharmacology (Berl) 1997, 132:35-43.
78. Collinson N., Kuenzi F.M., Jarolimek W., Maubach K.A., Cothliff R., Sur C., et al. Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor. J Neurosci 2002, 22:5572-5580.
79. Colorado R.A., Shumake J., Conejo N.M., Gonzalez-Pardo H., Gonzalez-Lima F. Effects of maternal separation, early handling, and standard facility rearing on orienting and impulsive behavior of adolescent rats. Behav Processes 2006, 71:51-58.
80. Cone J.D. Hierarchical views of anxiety: what do they profit us?. Behav Ther 1998, 29:325-332.
81. Cook M.N., Crounse M., Flaherty L. Anxiety in the elevated zero-maze is augmented in mice after repeated daily exposure. Behav Genet 2002, 32:113-118.
82. Copland A.M., Balfour D.J.K. Spontaneous activity and brain 5-hydroxyindole levels measured in rats tested in two designs of elevated X-maze. Life Sci 1987, 41:57-64.
83. Costall B., Hendric C.A., Kelly M.E., Nayior R.J. Actions of sulpiride and tiapride in a simple model of anxiety in mice. Neuropharmacology 1987, 26:295-300.
84. Costall B., Jones B.J., Kelly M.E., Naylor R.J., Tomkins D.M. Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol Biochem Behav 1989, 32:777-785.
85. Cottone P., Sabino V., Steardo L., Zorrilla E.P. FG 7142 specifically reduces meal size and the rate and regularity of sustained feeding in female rats: evidence that benzodiazepine inverse agonists reduce food palatability. Neuropharmacology 2007, 32:1069-1081.
86. Crabbe J.C., Wahlsten D., Dudek B.C. Genetics of mouse behavior: interactions with laboratory environment. Science 1999, 284:1670-1672.
87. Crawley J.N., Goodwin F.K. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 1980, 13:167-170.
88. Crawley J.N. Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol Biochem Behav 1981, 15:695-699.
89. Crawley J.N., Skolnick P., Paul S.M. Absence of intrinsic antagonist actions of benzodiazepine antagonist on an exploratory model of anxiety in the mouse. Neuropharmacology 1984, 5:531-537.
90. Crawley J.N. Exploratory behavior models of anxiety in mice. Neurosci Biobehav Rev 1985, 9:37-44.
91. Crestani F., Lorez M., Baer K., Essrich C., Benke D., Laurent J.P., et al. Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat Neurosci 1999, 2:833-839.
92. Crestani F., Keist R., Fritschy J.M., Benke D., Vogt K., Prut L., et al. Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors. Proc Natl Acad Sci U S A 2002, 99:8980-8985.
93. Cruz A.P., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav 1994, 49:171-176.
94. Cryan J.F., Dev K.K. The glutamatergic system as a potential therapeutic target for the treatment of anxiety disorders. Handbook of Anxiety and Fear 2008, vol. 17:269-301. Elsevier. R.J. Blanchard, D.C. Blanchard, G. Griebel, D. Nutt (Eds.).
95. Cunha C., Monfils M.-H., LeDoux J.E. GABAC receptors in the lateral amygdala: a possible novel target for the treatment of fear and anxiety disorders?. Front Behav Neurosci 2010, 4:6.
96. Dalvi A., Rodgers R.J. Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the disinhibition of open-arm avoidance. Pharmacol Biochem Behav 1999, 62:727-734.
97. Daly J.A., Hogg E., Sacks D., Smith M., Zimring L. Sex and relationship affect social self-grooming. J Nonverbal Behav 1983, 7:83-189.
98. Davis M., Shi C. The extended amygdala: are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety?. Ann N Y Acad Sci 1999, 877:281-291.
99. Davis M., Walker D.L., Miles L., Grillon C. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 2010, 35:105-135.
100. Dawson G.R., Crawford S.P., Collinson N., Iversen S.D., Tricklebank M.D. Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity. Psychopharmacology (Berl) 1995, 118:316-323.
101. Dawson G.R., Tricklebank M.D. Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol Sci 1995, 16:33-36.
102. de Boer S.F., Slangen J.L., van der Gugten J. Effects of chlordiazepoxide and buspirone on plasma catecholamine and corticosterone levels in rats under basal and stress conditions. Endocrinol Exp 1990, 24:229-239.
103. de Boer S.F., Koolhaas J.M. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis. Eur J Pharmacol 2005, 526:125-139.
104. de la Mora M.P., Gallegos-Cari A., Arizmendi-García Y., Marcellino D., Fuxe K. Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: structural and functional analysis. Prog Neurobiol 2010, 90:198-216.
105. Degroot A., Nomikos G.G. Genetic deletion of muscarinic M4 receptors is anxiolytic in the shock-probe burying model. Eur J Pharmacol 2006, 531:183-186.
106. Di Bitetti M.S. Evidence for an important social role of allogrooming in a platyrrhine primate. Anim Behav 1997, 54:199-211.
107. Di Lio A., Benke D., Besson M., Desmeules J., Daali Y., Wang Z.J., et al. HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain. Neuropharmacology 2011, 60:626-632.
108. Dias R., Sheppard W.F., Fradley R.L., Garrett E.M., Stanley J.L., Tye S.J., et al. Evidence for a significant role of α3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines. J Neurosci 2005, 25:10682-10688.
109. Diaz M.R., Chappell A.M., Christian D.T., Anderson N.J., McCool B.A. Dopamine D3-like receptors modulate anxiety-like behavior and regulate GABAergic transmission in the rat lateral/basolateral amygdala. Neuropsychopharmacology 2011, 36:1090-1103.
110. Dielenberg R.A., Carrive P., McGregor I.S. The cardiovascular and behavioral response to cat odor in rats: unconditioned and conditioned effects. Brain Res 2001, 897:228-237.
111. Dielenberg R.A., McGregor I.S. Defensive behavior in rats towards predatory odors: a review. Neurosci Biobehav Rev 2001, 25:597-609.
112. Dinsmoor J.A. Punishment: I. The avoidance hypothesis. Psychol Rev 1954, 61:34-46.
113. Dixon C.I., Morris H.V., Breen G., Desrivieres S., Jugurnauth S., Steiner R.C., et al. Cocaine effects on mouse incentive-learning and human addiction are linked to alpha2 subunit-containing GABAA receptors. Proc Natl Acad Sci U S A 2010, 107:2289-2294.
114. Drapier D., Bentué-Ferrer D., Laviolle B., Millet B., Allain H., Bourin M., et al. Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze. Behav Brain Res 2007, 176:202-209.
115. Ducottet C., Aubert A., Belzung C. Susceptibility to subchronic unpredictable stress is related to individual reactivity to threat stimuli in mice. Behav Brain Res 2004, 155:291-299.
116. Dulawa S.C., Holick K.A., Gundersen B., Hen R. Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 2004, 29:1321-1330.
117. Dygalo N.N., Shishkina G.T., Kalinina T.S., Yudina A.M., Ovchinnikova E.S. Effect of repeated treatment with fluoxetine on tryptophan hydroxylase-2 gene expression in the rat brainstem. Pharmacol Biochem Behav 2006, 85:220-227.
118. Enginar N., Hatipoglu I., Firtina M. Evaluation of the acute effects of amitriptyline and fluoxetine on anxiety using grooming analysis algorithm in rats. Pharmacol Biochem Behav 2008, 89:450-455.
119. Ennaceur A., Michalikova S., van Rensburg R., Chazot P.L. Models of anxiety: responses of mice to novelty and open spaces in a 3D maze. Behav Brain Res 2006, 174:9-38.
120. Ennaceur A., Michalikova S., Chazot P.L. Models of anxiety: rats' responses to novelty in an open space and an enclosed space. Behav Brain Res 2006, 171:26-49.
121. Ennaceur A., Michalikova S., van Rensburg R., Chazot P.L. Are benzodiazepines really anxiolytic? Evidence from a 3D maze spatial navigation task. Behav Brain Res 2008, 188:136-153.
122. Ennaceur A., Michalikova S., Chazot P.L. Do rats really express neophobia towards novel objects? Experimental evidence from exposure to novelty and to an object recognition task in an open space and an enclosed space. Behav Brain Res 2009, 197:417-434.
123. Ennaceur A., Michalikova S., van Rensburg R., Chazot P.L. Distinguishing anxiolysis and hyperactivity in an open space behavioral test. Behav Brain Res 2010, 207:84-98.
124. Ennaceur A., Michalikova S., van Rensburg R., Chazot P.L. Tolerance, sensitization and dependence to diazepam in Balb/c mice exposed to a novel open space anxiety test. Behav Brain Res 2010, 209:154-164.
125. Ennaceur A., Michalikova S., van Rensburg R., Chazot P.L. MK-801 increases the baseline level of anxiety in mice introduced to a spatial memory task without prior habituation. Neuropharmacology 2011, 61:981-991.
126. Ennaceur A. Omission of the habituation procedure in the acquisition of a working memory task - evidence from Balb/c, C57/BL6J, and CD-1 mice. Behav Brain Res 2011, 223:203-210.
127. Ennaceur A. Open space anxiety test in rodents: the elevated platform with steep slopes. Methods Mol Biol 2012, 829:177-191.
128. Epstein S. The nature of anxiety with emphasis upon its relationship to expectancy. Anxiety: Current trends in theory and research 1972, vol. 2:291-337. Academic Press, New York. C.D. Spielberger (Ed.).
129. Escorihuela R.M., Fernández-Teruel A., Gil L., Aguilar R., Tobeña A., Driscoll P. Inbred Roman high- and low-avoidance rats: differences in anxiety, novelty-seeking, and shuttlebox behaviors. Physiol Behav 1999, 67:19-26.
130. Estes W.K., Skinner B.F. Some quantitative properties of anxiety. J Exp Psychol 1941, 29:390-400.
131. Eysenck M.W., Derakshan N., Santos R., Calvo M.G. Anxiety and cognitive performance: attentional control theory. Emotion 2007, 7:336-353.
132. Fendt M., Endres T. 2,3,5-Trimethyl-3-thiazoline (TMT), a component of fox odor - just repugnant or really fear-inducing?. Neurosci Biobehav Rev 2008, 32:1259-1266.
133. Ferkin M.H., Leonard S.T., Heath L.A., Paz-y-Miño C. Self-grooming as a tactic used by prairie voles, Microtus ochrogaster, to enhance sexual communication. Ethology 2001, 107:939-949.
134. Ferkin M.H., Li H.Z. A battery of olfactory-based screens for phenotyping the social and sexual behaviors of mice. Physiol Behav 2005, 85:489-499.
135. Fernández Espejo E. Structure of the mouse behaviour on the elevated plus-maze test of anxiety. Behav Brain Res 1997, 86:105-112.
136. File S.E. Chlordiazepoxide-induced ataxia, muscle relaxation and sedation in the rat: effects of muscimol, picrotoxin and naloxone. Pharmacol Biochem Behav 1982, 17:1165-1170.
137. File S.E., Mabbutt P.S., Walker J.H. Comparison of adaptive responses in familiar and novel environments: modulatory factors. Ann N Y Acad Sci 1988, 525:69-79.
138. File S.E. Animal models of different anxiety states. Adv Biochem Psychopharmacol 1995, 48:93-113.
139. Fischer B.D., Atack J.R., Platt D.M., Reynolds D.S., Dawson G.R., Rowlett J.K. Contribution of GABA(A) receptors containing a3 subunits to the therapeutic-related and side effects of benzodiazepine-type drugs in monkeys. Psychopharmacology (Berl) 2011, 215:311-319.
140. Flügge G., Kramer M., Fuchs E. Chronic subordination stress in male tree shrews: replacement of testosterone affects behaviour and central alpha2-adrenoceptors. Physiol Behav 2001, 73:293-300.
141. Fokkema D.S., Smit K., van der Gugten J., Koolhaas J. A coherent pattern among social behavior, blood pressure, corticosterone and catecholamine measures in individual male rats. Physiol Behav 1988, 42:485-489.
142. Fone K.C.F., Shalders K., Fox Z.D., Arthur R., Marsden C.A. Increased 5-HT2C receptor responsiveness occurs on rearing rats in social isolation. Psychopharmacology (Berl) 1996, 123:346-352.
143. Frankowska M., Filip M., Przegalinski E. Effects of GABAB receptor ligands in animal tests of depression and anxiety. Pharmacol Rep 2007, 59:645-655.
144. Gentsch C., Lichtsteiner M., Feer H. Locomotor activity, defecation score and corticosterone levels during an open field exposure: a comparison among individually and group-housed rats, and genetically selected rat lines. Physiol Behav 1981, 27:183-186.
145. Gioiosa L., Chiarotti F., Alleva E., Laviola G. A trouble shared is a trouble halved: social context and status affect pain in mouse dyads. PLoS One 2009, 4:e4143.
146. Gispen W.H., Isaacson R.L. ACTH-induced excessive grooming in the rat. Pharmacol Ther 1981, 12:209-246.
147. Gleser G., Ulett G. The Saslow Screening Test as a measure of anxiety-proneness. J Clin Psychol 1952, 8:279-283.
148. Goes T.C., Antunes F.D., Teixeira-Silva F. Trait and state anxiety in animal models: Is there correlation?. Neurosci Lett 2009, 450:266-269.
149. Gomes K.S., Nunes-De-Souza R.L. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:1261-1269.
150. Grant E.C., MacKintosh J.H. A comparison of the social postures of some common laboratory rodents. Behaviour 1963, 21:246-259.
151. Gray J.A. The neuropsychology of anxiety. Br J Psychol 1978, 69:417-434.
152. Gray J.A., McNaughton N. The neuropsychology of anxiety: an enquiry into the functions of the septo-hippocampal system 2000, Oxford University Press.
153. Gregus A., Wintink A.J., Davis A.C., Kalynchuk L.E. Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats. Behav Brain Res 2005, 156:105-114.
154. Grewal S.S., Shepherd J.K., Bill D.J., Fletcher A., Dourish C.T. Behavioural and pharmacological characterisation of the canopy stretched attend posture test as a model of anxiety in mice and rats. Psychopharmacology (Berl) 1997, 133:29-38.
155. Griebel G., Sanger D.J., Perrault G. Further evidence for differences between non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands in murine models of "state" and "trait" anxiety. Neuropharmacology 1996, 35:1081-1091.
156. Griebel G., Rodgers R.J., Perrault G., Sanger D.J. Risk assessment behavior: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test. Pharmacol Biochem Behav 1997, 57:817-827.
157. Griebel G., Perrault G., Sanger D.J. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone. Psychopharmacology (Berl) 1998, 138:55-66.
158. Griebel G., Cohen C., Perrault G., Sanger D.J. Behavioral effects of acute and chronic fluoxetine in Wistar-Kyoto rats. Physiol Behav 1999, 67:315-320.
159. Griebel G. Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?. Pharmacol Ther 1999, 82:1-61.
160. Griebel G., Belzung C., Perrault G., Sanger D.J. Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psychopharmacology (Berl) 2000, 148:164-170.
161. Gross C., Hen R. The developmental origins of anxiety. Nat Rev Neurosci 2004, 5:545-552.
162. Hajizadeh Moghaddam A., Roohbakhsh A., Rostami P., Heidary-Davishani A., Zarrindast M.R. GABA and histamine interaction in the basolateral amygdala of rats in the plus-maze test of anxiety-like behaviors. Pharmacology 2008, 82:59-66.
163. Hall C., Ballachey E.L. A study of the rat's behavior in a field. A contribution to method in comparative psychology. Univ Calif Publ Psychol 1932, 6:1-12.
164. Hall F.S., Huang S., Fong G.W., Sundstrom J.M., Pert A. Differential basis of strain and rearing effects on open-field behavior in Fawn Hooded and Wistar rats. Physiol Behav 2000, 71:525-532.
165. Haller J., Barna I., Barsvari B., Gyimesi Pelczer K., Yasar S., Panlilio L.V., et al. Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats. Psychopharmacology (Berl) 2009, 204:607-616.
166. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959, 32:50-55.
167. Handa R.J., Cross M.K., George M., Gordon B.H., Burgess L.H., Cabrera T.M., et al. Neuroendocrine and neurochemical responses to novelty stress in young and old male F344 rats: effects of d-fenfluramine treatment. Pharmacol Biochem Behav 1993, 46:101-109.
168. Handley S.L., Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn Schmiedebergs Arch Pharmacol 1984, 327:1-5.
169. Handley S.L., McBlane J.W. An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs. J Pharmacol Toxicol Methods 1993, 29:129-138.
170. Hannigan J.H., Isaacson R.L. Conditioned excessive grooming in the rat after footshock: effect of naloxone and situational cues. Behav Neural Biol 1981, 33:280-292.
171. Harada K., Aota M., Inoue T., Matsuda R., Mihara T., Yamaji T., et al. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone. Eur J Pharmacol 2006, 553:171-184.
172. Harro J., Oreland L., Vasar E., Bradwejn J. Impaired exploratory behaviour after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation. Eur Neuropsychopharmacol 1995, 5:447-455.
173. Harvey S.C., Foster K.L., McKay P.F., Carroll M.R., Seyoum R., Woods J.E., et al. The GABA(A) receptor alpha1 subtype in the ventral pallidum regulates alcohol-seeking behaviors. J Neurosci 2002, 22:3765-3775.
174. Harvey B.H., Shahid M. Metabotropic and ionotropic glutamate receptors as neurobiological targets in anxiety and stress-related disorders: focus on pharmacology and preclinical translational models. Pharmacol Biochem Behav 2012, 100:775-800.
175. Hascoët M., Bourin M. A new approach to the light/dark procedure in mice. Pharmacol Biochem Behav 1998, 60:645-653.
176. Heisler L.K., Chu H.M., Brennan T.J., Danao J.A., Bajwa P., Parsons L.H., et al. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci U S A 1998, 95:15049-15054.
177. Hendrie C.A., Eilam D., Weiss S.M. Effects of diazepam and buspirone on the behaviour of wild voles (Microtus socialis) in two models of anxiety. Pharmacol Biochem Behav 1997, 58:573-576.
178. Hendrie C.A., Eilam D., Weiss S.M. Effects of diazepam and buspirone on the behaviour of wild voles (Microtus socialis) in two models of anxiety. Pharmacol Biochem Behav 1997, 58:573-576.
179. Hendrie C.A., Van Driel K.S., Talling J.C., Inglis I.R. PBI creams: a spontaneously mutated mouse strain showing wild animal-type reactivity. Physiol Behav 2001, 74:621-628.
180. Hilakivi L.A., Lister R.G. Correlations between behavior of mice in Porsolt's swim test and in tests of anxiety, locomotion, and exploration. Behav Neural Biol 1990, 53:153-159.
181. Hill M.N., Gorzalka B.B. Enhancement of anxiety-like responsiveness to the cannabinoid CB1 receptor agonist HU-210 following chronic stress. Eur J Pharmacol 2004, 499:291-295.
182. Ho Y.-J., Eichendorff J., Schwarting R.K.W. Individual response profiles of male Wistar rats in animal models for anxiety and depression. Behav Brain Res 2002, 136:1-12.
183. Hofmann M., Kordás K.S., Gravius A., Bölcskei K., Parsons C.G., Dekundy A., et al. Assessment of the effects of NS11394 and L-838417, a2/3 subunit-selective GABA(A) [corrected] receptor-positive allosteric modulators, in tests for pain, anxiety, memory and motor function. Behav Pharmacol 2012, 23:790-801.
184. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 1996, 54:21-30.
185. Holmes A., Rodgers R.J. Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state?. Pharmacol Biochem Behav 1998, 60:473-488.
186. Holmes A., Rodgers R.J. Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Neurosci Biobehav Rev 1999, 23:971-980.
187. Holmes A., Parmigiani S., Ferrari P.F., Palanza P., Rodgers R.J. Behavioral profile of wild mice in the elevated plus-maze test for anxiety. Physiol Behav 2000, 71:509-516.
188. Holmes A., Iles J.P., Mayell S.J., Rodgers R.J. Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test. Behav Brain Res 2001, 122:159-167.
189. Holmes A., Heilig M., Rupniak N.M., Steckler T., Griebel G. Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol Sci 2003, 24:580-588.
190. Holmes A., Kinney J.W., Wrenn C.C., Li Q., Yang R.J., Ma L., et al. Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze. Neuropsychopharmacology 2003, 28:1031-1044.
191. Holmes A., Cryan J.F. Modeling human anxiety and depression in mutant mice. Contemporary clinical neuroscience: transgenic and knockout models of neuropsychiatric disorders 2006, 237-263. Humana Press Inc., Totowa, NJ. G.S. Fisch, J. Flint (Eds.).
192. Horváth J., Szögi T., Müller G., Szegedi V. The anxiolytic buspirone shifts coping strategy in novel environmental context of mice with different anxious phenotype. Behav Brain Res 2013, 250:32-38.
193. Ide S., Sora I., Ikeda K., Minami M., Uhl G.R., Ishihara K. Reduced emotional and corticosterone responses to stress in mu-opioid receptor knockout mice. Neuropharmacology 2010, 58:241-247.
194. Itoi K., Sugimoto N. The brainstem noradrenergic systems in stress, anxiety and depression. J Neuroendocrinol 2010, 22:355-361.
195. Jacobson L.H., Cryan J.F. Evaluation of the anxiolytic-like profile of the GABAB receptor positive modulator CGP7930 in rodents. Neuropharmacology 2008, 54:854-862.
196. Jakovcevski M., Schachner M., Morellini F. Individual variability in the stress response of C57BL/6J male mice correlates with trait anxiety. Genes Brain Behav 2008, 7:235-243.
197. Jones N., Duxon M.S., King S.M. Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents. Psychopharmacology (Berl) 2002, 161:314-323.
198. Jones N., King S.M., Duxon M.S. Further evidence for the predictive validity of the unstable elevated exposed plus-maze, a model of extreme anxiety in rats: differential effects of fluoxetine and chlordiazepoxide. Behav Pharmacol 2002, 13:525-535.
199. June H.L., Harvey S.C., Foster K.L., McKay P.F., Cummings R., Garcia M., et al. GABA(A) receptors containing (alpha)5 subunits in the CA1 and CA3 hippocampal fields regulate ethanol-motivated behaviors: an extended ethanol reward circuitry. J Neurosci 2001, 21:2166-2177.
200. June H.L., Foster K.L., McKay P.F., Seyoum R., Woods J.E., Harvey S.C., et al. The reinforcing properties of alcohol are mediated by GABA(A1) receptors in the ventral pallidum. Neuropsychopharmacology 2003, 28:2124-2137.
201. Kabbaj M., Devine D.P., Savage V.R., Akil H. Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules. J Neurosci 2000, 20:6983-6988.
202. Kaesermann H.P. Stretched attend posture, a non-social form of ambivalence, is sensitive to a conflict-reducing drug action. Psychopharmacology (Berl) 1986, 89:31-37.
203. Kalueff A.V., Tuohimaa P. Grooming analysis algorithm for neurobehavioural stress research. Brain Res Protocol 2004, 13:151-158.
204. Kalueff A.V., Tuohimaa P. The grooming analysis algorithm discriminates between different levels of anxiety in rats: potential utility for neurobehavioural stress research. J Neurosci Methods 2005, 143:169-177.
205. Kalynchuk L.E., Pinel J.P., Treit D., Kippin T.E. Changes in emotional behavior produced by long-term amygdala kindling in rats. Biol Psychiatry 1997, 41:438-451.
206. Kalynchuk L.E., Pinel J.P., Treit D. Long-term kindling and interictal emotionality in rats: effect of stimulation site. Brain Res 1998, 779:149-157.
207. Kalynchuk L.E., Gregus A., Boudreau D., Perrot-Sinal T.S. Corticosterone increases depression-like behavior, with some effects on predator odor-induced defensive behavior, in male and female rats. Behav Neurosci 2004, 118:1365-1377.
208. Kataoka M., Yamamori S., Suzuki E., Watanabe S., Sato T., Miyaoka H., et al. A single amino acid mutation in SNAP-25 induces anxiety-related behavior in mouse. PLoS One 2011, 6:e25158.
209. Kemble E.D., Bolwahnn B.L. Immediate and long-term effects of novel odors on risk assessment in mice. Physiol Behav 1997, 61:543-549.
210. Kent J.M., Mathew S.J., Gorman J.M. Molecular targets in the treatment of anxiety. Biol Psychiatry 2002, 52:1008-1030.
211. Kim H., Shimojo S., O'Doherty J.P. Is avoiding an aversive outcome rewarding? Neural substrates of avoidance learning in the human brain. PLoS Biol 2006, 4:e233.
212. Kim S., Lee S., Ryu S., Suk J., Park C. Comparative analysis of the anxiety-related behaviors in four inbred mice. Behav Process 2002, 60:181-190.
213. King S.M. Escape-related behaviors in an unstable, elevated and exposed environment: I. A new behavioral model of extreme anxiety. Behav Brain Res 1999, 98:113-126.
214. King S.M. Escape-related behaviors in an unstable, elevated and exposed environment: II. Long-term sensitization after repetitive electrical stimulation of the rodent midbrain defense system. Behav Brain Res 1999, 98:127-142.
215. Knabl J., Witschi R., Hösl K., Reinold H., Zeilhofer U.B., Ahmadi S., et al. Reversal of pathological pain through specific spinal GABAA receptor subtypes. Nature 2008, 451:330-334.
216. Knabl J., Zeilhofer U.B., Crestani F., Rudolph U., Zeilhofer H.U. Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice. Pain 2009, 141:233-238.
217. Kks S., Beljajev S., Koovit I., Abramov U., Bourin M., Vasar E. 8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze. Psychopharmacology (Berl) 2001, 153:365-372.
218. Komorowska J., Pisula W. Does changing levels of stress affect the characteristics of grooming behavior in rats?. Int J Comp Psychol 2003, 16:237-246.
219. Kondratova A.A., Dubrovsky Y.V., Antoch M.P., Kondratov R.V. Circadian clock proteins control adaptation to novel environment and memory formation. Aging 2010, 2:285-297.
220. Kopp C., Rudolph U., Low K., Tobler I. Modulation of rhythmic brain activity by diazepam: GABA(A) receptor subtype and state specificity. Proc Natl Acad Sci U S A 2004, 101:3674-3679.
221. Korpi E.R., Sinkkonen S.T. GABA(A) receptor subtypes as targets for neuropsychiatric drug development. Pharmacol Ther 2006, 109:12-32.
222. Korte S.M., De Boer S.F. A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze. Eur J Pharmacol 2003, 463:163-175.
223. Kralic J.E., O'Buckley T.K., Khisti R.T., Hodge C.W., Homanics G.E., Morrow A.L. GABA(A) receptor alpha-1 subunit deletion alters receptor subtype assembly, pharmacological and behavioral responses to benzodiazepines and zolpidem. Neuropharmacology 2002, 43:685-694.
224. Kralic J.E., Wheeler M., Renzi K., Ferguson C., O'Buckley T.K., Grobin A.C., et al. Deletion of GABAA receptor alpha 1 subunit-containing receptors alters responses to ethanol and other anesthetics. J Pharmacol Exp Ther 2003, 305:600-607.
225. Kramer M., Hiemke C., Fuchs E. Chronic psychosocial stress and antidepressant treatment in tree shrews: time-dependant behavioural and endocrine effects. Neurosci Biobehav Rev 1999, 23:937-947.
226. Lacosta S., Merali Z., Anisman H. Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects. Brain Res 1999, 818:291-303.
227. Lader M. Anxiety: its nature and treatment. S Afr Med J 1975, 49:939-943.
228. Lalonde R., Strazielle C. Relations between open-field, elevated plus-maze, and emergence tests as displayed by C57/BL6J and BALB/c mice. J Neurosci Methods 2008, 171:48-52.
229. Lampis V., Maziade M., Battaglia M. Animal models of human anxiety disorders: reappraisal from a developmental psychopathology vantage point. Pediatr Res 2011, 69:77R-84R.
230. Lamprea M.R., Cardenas F.P., Setem J., Morato S. Thigmotactic responses in an open-field. Braz J Med Biol Res 2008, 41:135-140.
231. Landgraf R., Wigger A., Holsboer F., Neumann I.D. Hyper-reactive hypothalamo-pituitary-adrenocortical axis in rats bred for high anxiety-related behaviour. J Neuroendocrinol 1999, 11:405-407.
232. Lazarus R.S. Emotion and adaptation 1991, Oxford University Press.
233. LeDoux J.E. Emotion circuits in the brain. Annu Rev Neurosci 2000, 23:155-184.
234. Leggio G.M., Micale V., Le Foll B., Mazzola C., Nobrega J.N., Drago F. Dopamine D3 receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepam. Eur Neuropsychopharmacol 2011, 21:325-332.
235. Leonardo E.D., Hen R. Anxiety as a developmental disorder. Neuropsychopharmacology 2008, 33:134-140.
236. Lepicard E.M., Joubert C., Hagneau I., Perez-Diaz F., Chapouthier G. Differences in anxiety-related behavior and response to diazepam in BALB/cByJ and C57BL/6J strains of mice. Pharmacol Biochem Behav 2000, 67:739-748.
237. Lever C., Burton S., O'Keefe J. Rearing on hind legs, environmental novelty, and the hippocampal formation. Rev Neurosci 2006, 17:111-133.
238. Levin E.D., Bencan Z., Cerutti D.T. Anxiolytic effects of nicotine in zebrafish. Physiol Behav 2007, 90:54-58.
239. Lewis D.A., Cho R.Y., Carter C.S., Eklund K., Forster S., Kelly M.A., et al. Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia. Am J Psychiatry 2008, 165:1585-1593.
240. Liebsch G., Landgraf R., Engelmann M., Lörscher P., Holsboer F. Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain. J Psychiatr Res 1999, 33:153-163.
241. Linden A.-M., Schoepp D.D. Metabotropic glutamate receptor targets for neuropsychiatric disorders. Drug Discov Today Ther Strateg 2006, 3:507-517.
242. Lipska B.K., Weinberger D.R. To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 2000, 23:223-239.
243. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 1987, 92:180-185.
244. Lister R.G. Ethologically-based animal models of anxiety disorders. Pharmacol Ther 1990, 46:321-340.
245. Lohr J.M., Olatunji B.O., Sawchuk C.N. A functional analysis of danger and safety signals in anxiety disorders. Clin Psychol Rev 2007, 27:114-126.
246. Lopez-Aumatell R., Guitart-Masip M., Vicens-Costa E., Gimenez-Llort L., Valdar W., Johannesson M., et al. Fearfulness in a large N/Nih genetically heterogeneous rat stock: differential profiles of timidity and defensive flight in males and females. Behav Brain Res 2008, 188:41-55.
247. Lovibond P.F., Saunders J.C., Weidemann G., Mitchell C.J. Evidence for expectancy as a mediator of avoidance and anxiety in a laboratory model of human avoidance learning. Q J Exp Psychol 2008, 61:1199-1216.
248. Löw K., Crestani F., Keist R., Benke D., Brünig I., Benson J.A., et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 2000, 290:131-134.
249. Lowry C.A., Johnson P.L., Hay-Schmidt A., Mikkelsen J., Shekhar A. Modulation of anxiety circuits by serotonergic systems. Stress 2005, 8:233-246.
250. Lund T.D., Rovis T., Chung W.C., Handa R.J. Novel actions of estrogen receptor-beta on anxiety-related behaviors. Endocrinology 2005, 146:797-807.
251. Luo D.D., An S.C., Zhang X. Involvement of hippocampal serotonin and neuropeptide Y in depression induced by chronic unpredicted mild stress. Brain Res Bull 2008, 77:8-12.
252. MacLean R.R., Datta S. The relationship between anxiety and sleep-wake behavior after stressor exposure in the rat. Brain Res 2007, 1164:72-80.
253. Maestripieri D., Martel F.L., Nevison C.M., Simpson M.J.A., Keverne E.B. Anxiety in rhesus monkey infants in relation to interactions with their mother and other social companions. Dev Psychobiol 1992, 24:571-581.
254. Maier S.F. Learned helplessness: relationships with fear and anxiety. Stress: an integrated approach 1993, 207-243. Academic Press, London. C. Standford, P. Salmon (Eds.).
255. Mairesse J., Viltart O., Salomé N., Giuliani A., Catalani A., Casolini P., et al. Prenatal stress alters the negative correlation between neuronal activation in limbic regions and behavioral responses in rats exposed to high and low anxiogenic environments. Psychoneuroendocrinology 2007, 32:765-776.
256. Makino J., Kato K., Maes F.W. Temporal structure of open-field behavior in inbred strains of mice. Jpn Psychol Res 1991, 33:145-152.
257. Marks I.M. Fears, phobias, and rituals. Panic, anxiety, and their disorders 1987, Oxford University Press, New York.
258. Marler P. Communications in monkeys and apes. Primate behavior 1965, 544-584. Holt, Rinehart & Winston Inc., New York. I. DeVore (Ed.).
259. Márquez C., Nadal R., Armario A. Influence of reactivity to novelty and anxiety on hypothalamic-pituitary-adrenal and prolactin responses to two different novel environments in adult male rats. Behav Brain Res 2006, 168:13-22.
260. Martin J.R., Moreau J.L., Jenck F., Cumin R. Acute and chronic administration of buspirone fails to yield anxiolytic-like effects in a mouse operant punishment paradigm. Pharmacol Biochem Behav 1993, 46:905-910.
261. Mathiasen L.S., Mirza N.R., Rodgers R.J. Strain- and model-dependent effects of chlordiazepoxide, L-838,417 and zolpidem on anxiety-like behaviours in laboratory mice. Pharmacol Biochem Behav 2008, 90:19-36.
262. Matuszewich L., Karney J.J., Carter S.R., Janasik S.P., O'Brien J.L., Friedman R.D. The delayed effects of chronic unpredictable stress on anxiety measures. Physiol Behav 2007, 90:674-681.
263. McFarlane H.G., Kusek G.K., Yang M., Phoenix J.L., Bolivar V.J., Crawley J.N. Autism-like behavioral phenotypes in BTBR T+tf/J mice. Genes Brain Behav 2008, 7:152-163.
264. McGregor I.S., Schrama L., Ambermoon P., Dielenberg R.A. Not all 'predator odours' are equal: cat odour but not 2,4,5 trimethylthiazoline (TMT; fox odour) elicits specific defensive behaviours in rats. Behav Brain Res 2002, 129:1-16.
265. McGregor I.S., Hargreaves G.A., Apfelbach R., Hunt G.E. Neural correlates of cat odor-induced anxiety in rats: region-specific effects of the benzodiazepine midazolam. J Neurosci 2004, 24:4134-4144.
266. McKernan R.M., Rosahl T.W., Reynolds D.S., Sur C., Wafford K.A., Atack J.R., et al. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci 2000, 3:587-592.
267. McNaughton N., Gray J.A. Anxiolytic action on the behavioural inhibition system implies multiple types of arousal contribute to anxiety. J Affect Disord 2000, 61:161-176.
268. McNaughton N., Corr P.J. A two-dimensional neuropsychology of defense: fear/anxiety and defensive distance. Neurosci Biobehav Rev 2004, 28:285-305.
269. McNaughton N., Corr P.J. The neuropsychology of fear and anxiety: a foundation for reinforcement sensitivity theory. The reinforcement sensitivity theory of personality 2008, 44-94. Cambridge University Press. P.J. Corr (Ed.).
270. Meerlo P., Sgoifo A. Long-lasting consequences of a social conflict in rats: behavior during the interaction predicts subsequent changes in daily rhythms of heart rate, temperature, and activity. Behav Neurosci 1999, 113:1283-1290.
271. Mendes-Gomes J., Miguel T.T., Amaral V.C., Nunes-de-Souza R.L. Corticosterone does not change open elevated plus maze-induced antinociception in mice. Horm Behav 2011, 60:408-413.
272. Merali Z., Levac C., Anisman H. Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice. Biol Psychiatry 2003, 54:552-565.
273. Michalikova S., van Rensburg R., Chazot P.L., Ennaceur A. Anxiety responses in Balb/c, c57 and CD-1 mice exposed to a novel open space test. Behav Brain Res 2010, 207:402-417.
274. Miczek K.A. Intraspecies aggression in rats: effects of d-amphetamine and chlordiazepoxide. Psychopharmacologia 1974, 39:275-301.
275. Miczek K.A., Barry H. δ9-Tetrahydrocannabinol and aggressive behavior in rats. Behav Biol 1974, 11:261-267.
276. Mikics E., Barsy B., Barsvári B., Haller J. Behavioral specificity of non-genomic glucocorticoid effects in rats: effects on risk assessment in the elevated plus-maze and the open-field. Horm Behav 2005, 48:152-162.
277. Milic M., Divljakovic J., Rallapalli S., van Linn M.L., Timic T., Cook J.M., et al. The role of a1 and a5 subunit-containing GABAA receptors in motor impairment induced by benzodiazepines in rats. Behav Pharmacol 2012, 23:191-197.
278. Miller N.E. Studies of fear as an acquirable drive: I. Fear as motivation and fear-reduction as reinforcement in the learning of new responses. J Exp Psychol 1948, 38:89-101.
279. Milner L.C., Crabbe J.C. Three murine anxiety models: results from multiple inbred strain comparisons. Genes Brain Behav 2008, 7:496-505.
280. Misslin R., Cigrang M. Does neophobia necessarily imply fear or anxiety?. Behav Process 1986, 12:45-50.
281. Mombereau C., Kaupmann K., Froestl W., Sansig G., van der Putten H., Cryan J.F. Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior. Neuropsychopharmacology 2004, 29:1050-1062.
282. Montgomery K.C. The relation between fear induced by novel stimulation and exploratory behavior. J Comp Physiol Psychol 1955, 48:254-260.
283. Moreira F.A., Wotjak C.T. Cannabinoids and anxiety. Curr Top Behav Neurosci 2010, 2:429-450.
284. Morris H.V., Dawson G.R., Reynolds D.S., Atack J.R., Stephens D.N. Both alpha2 and alpha3 GABAA receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigm. Eur J Neurosci 2006, 23:2495-2504.
285. Morris H.V., Dawson G.R., Reynolds D.S., Atack J.R., Rosahl T.W., Stephens D.N. Alpha2-containing GABAA receptors are involved in mediating stimulant effects of cocaine. Pharmacol Biochem Behav 2008, 90:9-18.
286. Morris H.V., Nilsson S., Dixon C.I., Stephens D.N., Clifton P.G. a1- and a2-containing GABAA receptor modulation is not necessary for benzodiazepine-induced hyperphagia. Appetite 2009, 52:675-683.
287. Moy S.S., Nadler J.J., Young N.B., Perez A., Holloway L.P., Barbaro R.P., et al. Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav Brain Res 2007, 176:4-20.
288. Munro G., Erichsen H.K., Rae M.G., Mirza N.R. A question of balance-positive versus negative allosteric modulation of GABA(A) receptor subtypes as a driver of analgesic efficacy in rat models of inflammatory and neuropathic pain. Neuropharmacology 2011, 61:121-132.
289. Muris P. Normal and abnormal fear and anxiety in children and adolescents 2010, Elsevier Science.
290. Murray F., Smith D.W., Hutson P.H. Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice. Eur J Pharmacol 2008, 583:115-127.
291. Nemati F., Whishaw I.Q. The point of entry contributes to the organization of exploratory behavior of rats on an open field: an example of spontaneous episodic memory. Behav Brain Res 2007, 182:119-128.
292. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nat Neurosci 2010, 13:1161-1169.
293. Nic Dhonnchadha B.A., Bourin M., Hascoët M. Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety. Behav Brain Res 2003, 140:203-214.
294. Oh J.E., Zupan B., Gross S., Toth M. Paradoxical anxiogenic response of juvenile mice to fluoxetine. Neuropsychopharmacology 2009, 34:2197-2207.
295. Ohl F. Testing for anxiety. Clin Neurosci Res 2003, 3:233-238.
296. Öhman A., Mineka S. Fears, phobias, and preparedness: toward an evolved module of fear and fear learning. Psychol Rev 2001, 108:483-522.
297. Öhman A. Fear and anxiety. Handbook of emotions 2008, 709-729. The Guilford Press, [ch 44]. M. Lewis, J.M. Haviland-Jones, L.F. Barrett (Eds.).
298. Oliveira-Dos-Santos A.J., Matsumoto G., Snow B.E., Bai D., Houston F.P., Whishaw I.Q., et al. Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc Natl Acad Sci U S A 2000, 97:12272-12277.
299. Pähkla R., Kask A., Rägo L. Differential effects of beta-carbolines and antidepressants on rat exploratory activity in the elevated zero-maze. Pharmacol Biochem Behav 2000, 65:737-742.
300. Panickar K.S. Dose-response analysis of the effects of buspirone on rearing in rats. J Psychopharmacol 1991, 5:72-76.
301. Pape H.C., Jüngling K., Seidenbecher T., Lesting J., Reinscheid R.K. Neuropeptide S: a transmitter system in the brain regulating fear and anxiety. Neuropharmacology 2010, 58:29-34.
302. Patel S., Hillard C.J. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. JPET 2006, 318:304-311.
303. Pawlak C.R., Schwarting R.K. Object preference and nicotine consumption in rats with high versus low rearing activity in a novel open field. Pharmacol Biochem Behav 2002, 73:679-687.
304. Peça J., Feliciano C., Ting J.T., Wang W., Wells M.F., Venkatraman T.N., et al. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 2011, 472:437-442.
305. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985, 14:149-167.
306. Perkins A.M., Kemp S.E., Corr P.J. Fear and anxiety as separable emotions: an investigation of the revised reinforcement sensitivity theory of personality. Emotion 2007, 7:252-261.
307. Perrot-Sinal T.S., Gregus A., Boudreau D., Kalynchuk L.E. Sex and repeated restraint stress interact to affect cat odor-induced defensive behavior in adult rats. Brain Res 2004, 1027:161-172.
308. Pinel J.P.J., Mana M.J. Adaptive interactions of rats with dangerous inanimate objects: support for a cognitive theory of defensive behavior. Ethoexperimental approaches to the study of behavior 1989, 137-150. Kluwer Academic Publishers, Dordrecht. R.J. Blanchard, P.F. Brain, D.C. Blanchard, S. Parmigiani (Eds.).
309. Pobbe R.L., Defensor E.B., Pearson B.L., Bolivar V.J., Blanchard D.C., Blanchard R.J. General and social anxiety in the BTBR T+tf/J mouse strain. Behav Brain Res 2011, 216:446-451.
310. Podhorna J., Franklin K.B. Long-lasting increase in anxiety after electrolytic lesions of the pedunculopontine tegmental nucleus. Behav Neurosci 1999, 113:550-557.
311. Podhorna J., Brown R.E. Strain differences in activity and emotionality do not account for differences in learning and memory performance between C57BL/6 and DBA/2 mice. Genes Brain Behav 2002, 1:96-110.
312. Pohl J., Olmstead M.C., Wynne-Edwards K.E., Harkness K., Menard J.L. Repeated exposure to stress across the childhood-adolescent period alters rats' anxiety- and depression-like behaviors in adulthood: the importance of stressor type and gender. Behav Neurosci 2007, 121:462-474.
313. Pohorecky L.A. Psychosocial stress and chronic ethanol ingestion in male rats: effects on elevated plus maze behavior and ultrasonic vocalizations. Physiol Behav 2008, 94:432-447.
314. Price E.O. Some behavioral differences between wild and domestic Norway rats: gnawing and platform jumping. Anim Learn Behav 1973, 1:312-316.
315. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 2003, 463:3-33.
316. Prut L., Prenosil G., Willadt S., Vogt K., Fritschy J.M., Crestani F. A reduction in hippocampal GABAA receptor alpha5 subunits disrupts the memory for location of objects in mice. Genes Brain Behav 2010, 9:478-488.
317. Rachman S., Craske M., Tallman K. Does escape behavior strengthen agoraphobic avoidance? A replication. Behav Ther 1986, 17:366-384.
318. Ramos A., Berton O., Mormede P., Chaouloff F. A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behav Brain Res 1997, 85:57-69.
319. Ramos A., Mormede P. Stress and emotionality: a multidimensional and genetic approach. Neurosci Biobehav Rev 1998, 22:33-57.
320. Reiss S. Trait anxiety: it's not what you think it is. J Anxiety Disord 1997, 11:201-214.
321. Renner M.J. Neglected aspects of exploratory and investigatory behavior. Psychobiology 1990, 18:16-22.
322. Ressler K.J., Mayberg H.S. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci 2007, 10:1116-1124.
323. Reynolds L.M., Engin E., Tantillo G., Lau H.M., Muschamp J.W., Carlezon W.A., et al. Differential roles of GABAA receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation reward. Neuropsychopharmacology 2012, 37:2531-2540.
324. Rhudy J.L., Meagher M.W. Fear and anxiety: divergent effects on human pain thresholds. Ann NY Acad Sci 1997, 821:305-331.
325. Rizk A., Curley J., Robertson J., Raber J. Anxiety and cognition in histamine H3 receptor-/- mice. Eur J Neurosci 2004, 19:1992-1996.
326. Robert G., Drapier D., Bentué-Ferrer D., Renault A., Reymann J.M. Acute and chronic anxiogenic-like response to fluoxetine in rats in the elevated plus-maze: modulation by stressful handling. Behav Brain Res 2011, 220:344-348.
327. Rodgers R.J., Blanchard D.C., Wong L.K., Blanchard R.J. Effects of scopolamine on antipredator defense reactions in wild and laboratory rats. Pharmacol Biochem Behav 1990, 36:575-583.
328. Rodgers R.J., Cole J.C. Anxiety enhancement in the murine elevated plus maze by immediate prior exposure to social stressors. Physiol Behav 1993, 53:383-388.
329. Rodgers R.J., Johnson N.J. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 1995, 52:297-303.
330. Rodgers R.J. Animal models of 'anxiety': where next?. Behav Pharmacol 1997, 8:477-496.
331. Rodgers R.J., Dalvi A. Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev 1997, 21:801-810.
332. Rodgers R.J., Cao B.J., Dalvi A., Holmes A. Animal models of anxiety: an ethological perspective. Braz J Med Biol Res 1997, 30:289-304.
333. Rodgers R.J., Cutler M.G., Jackson J.E. Behavioural effects in mice of subchronic buspirone, ondansetron and tianeptine. II. The elevated plus-maze. Pharmacol Biochem Behav 1997, 56:295-303.
334. Rodgers R.J., Haller J., Holmes A., Halasz J., Walton T.J., Brain P.F. Corticosterone response to the plus-maze: high correlation with risk assessment in rats and mice. Physiol Behav 1999, 68:47-53.
335. Rodgers R.J., Boullier E., Chatzimichalaki P., Cooper G.D., Shorten A. Contrasting phenotypes of C57BL/6JOlaHsd, 129S2/SvHsd and 129/SvEv mice in two exploration-based tests of anxiety-related behaviour. Physiol Behav 2002, 77:301-310.
336. Rodgers R.J., Davies B., Shore R. Absence of anxiolytic response to chlordiazepoxide in two common background strains exposed to the elevated plus-maze: importance and implications of behavioural baseline. Genes Brain Behav 2002, 1:242-251.
337. Roelofs J., Huibers M., Peeters F., Arntz A., van Os J. Rumination and worrying as possible mediators in the relation between neuroticism and symptoms of depression and anxiety in clinically depressed individuals. Behav Res Ther 2008, 46:1283-1289.
338. Rosen J.B., Pagani J.H., Rolla K.L., Davis C. Analysis of behavioral constraints and the neuroanatomy of fear to the predator odor trimethylthiazoline: a model for animal phobias. Neurosci Biobehav Rev 2008, 32:1267-1276.
339. Roth K.A., Katz R.J. Stress, behavioral arousal, and open field activity a reexamination of emotionality in the rat. Neurosci Biobehav Rev 1979, 3:247-263.
340. Rowlett J.K., Lelas S. Comparison of zolpidem and midazolam self-administration under progressive-ratio schedules: consumer demand and labor supply analyses. Exp Clin Psychopharmacol 2007, 15:328-337.
341. Roy V., Chapillon P., Jeljeli M., Caston J., Belzung C. Free versus forced exposure to an elevated plus-maze: evidence for new behavioral interpretations during test and retest. Psychopharmacology (Berl) 2009, 2(03):131-141.
342. Rudolph U., Möhler H. GABA-based therapeutic approaches: GABAA receptor subtype functions. Curr Opin Pharmacol 2006, 6:18-23.
343. Russell J.A. Stress, anxiety and the amygdala. Stress 2005, 8:207-208.
344. Salkovskis P.M. Obsessional-compulsive problems: a cognitive-behavioural analysis. Behav Res Ther 1985, 23:571-583.
345. Salomé N., Salchner P., Viltart O., Sequeira H., Wigger A., Landgraf R., et al. Neurobiological correlates of high (HAB) versus low anxiety-related behavior (LAB): differential Fos expression in HAB and LAB rats. Biol Psychiatry 2004, 55:715-723.
346. Salomons A.R., Pinzon N.E., Boleij H., Kirchhoff S., Arndt S.S., Nordquist R.E., et al. Differential effects of diazepam and MPEP on habituation and neuro-behavioural processes in inbred mice. Behav Brain Funct 2012, 8:30.
347. Salum C., Roque-da-Silva A.C., Morato S. Conflict as a determinant of rat behavior in three types of elevated plus-maze. Behav Processes 2003, 63:87-93.
348. Savic M.M., Huang S., Furtmüller R., Clayton T., Huck S., Obradovic D.I., et al. Are GABAA receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists?. Neuropsychopharmacology 2008, 33:332-339.
349. Savic M.M., Milinkovic M.M., Rallapalli S., Clayton T., Joksimovic S., Van Linn M., et al. The differential role of alpha1- and alpha5-containing GABA(A) receptors in mediating diazepam effects on spontaneous locomotor activity and water-maze learning and memory in rats. Int J Neuropsychopharmacol 2009, 12:1179-1193.
350. Savic M.M., Majumder S., Huang S., Edwankar R.V., Furtmüller R., Joksimovic S., et al. Novel positive allosteric modulators of GABAA receptors: do subtle differences in activity at alpha1 plus alpha5 versus alpha2 plus alpha3 subunits account for dissimilarities in behavioral effects in rats?. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:376-386.
351. Sayin Ü., Purali N., Özkan T., Altug T., Büyükdevrim S. Vigabatrin has an anxiolytic effect in the elevated plus-maze test of anxiety. Pharmacol Biochem Behav 1992, 43:529-535.
352. Schino G., Perretta G., Taglioni A.M., Monaco V., Troisi A. Primate displacement activities as an ethopharmacological model of anxiety. Anxiety 1996, 2:186-191.
353. Schoenfeld W.N. An experimental approach to anxiety, escape, and avoidance behavior. Anxiety 1950, 70-99. Grune & Stratton, New York. P.H. Hoch, J. Zubin (Eds.).
354. Schwarting R.K.W., Thiel C.M., Müller C.P., Huston J.P. Relationship between anxiety and serotonin in the ventral striatum. Neuroreport 1998, 9:1025-1029.
355. Schwartz G.E., Weinberger D.A. Patterns of emotional responses to affective situations: relations among happiness, sadness, anger, fear, depression, and anxiety. Motiv Emot 1980, 4:175-191.
356. Selcher J.C., Nekrasova T., Paylor R., Landreth G.E., Sweatt J.D. Mice lacking the ERK1 isoform of MAP kinase are unimpaired in emotional learning. Learn Mem 2001, 8:11-19.
357. Selleri S., Bruni F., Costagli C., Costanzo A., Guerrini G., Ciciani G., et al. A novel selective GABA(A) alpha1 receptor agonist displaying sedative and anxiolytic-like properties in rodents. J Med Chem 2005, 48:6756-6760.
358. Setem J., Pinheiro A.P., Motta V.A., Morato S., Cruz A.P. Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze. Pharmacol Biochem Behav 1999, 62:515-521.
359. Shepard J.D., Myers D.A. Strain differences in anxiety-like behavior: association with corticotropin-releasing factor. Behav Brain Res 2008, 186:239-245.
360. Shepherd J.K., Grewal S.S., Fletcher A., Bill D.J., Dourish C.T. Behavioural and pharmacological characterisation of the elevated 'zero-maze' as an animal model of anxiety. Psychopharmacology (Berl) 1994, 116:56-64.
361. Shmelkov S.V., Hormigo A., Jing D., Proenca C.C., Bath K.G., Milde T., et al. Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice. Nat Med 2010, 16:598-602.
362. Silva M.T., Alves C.R., Santarem E.M. Anxiogenic-like effect of acute and chronic fluoxetine on rats tested on the elevated plus-maze. Braz J Med Biol Res 1999, 32:333-339.
363. Silva R.C.B., Brandão M.L. Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis. Pharmacol Biochem Behav 2000, 65:209-216.
364. Silverman J.L., Tolu S.S., Barkan C.L., Crawley J.N. Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology 2010, 35:976-989.
365. Silverman J.L., Yang M., Turner S.M., Katz A.M., Bell D.B., Koenig J.I., et al. Low stress reactivity and neuroendocrine factors in the BTBR T+tf/J mouse model of autism. Neuroscience 2010, 171:1197-1208.
366. Singh S.D. Conditioned emotional response in the rat: I. Constitution and situational determinants. J Comp Physiol Psychol 1959, 52:574-578.
367. Smith K.S., Engin E., Meloni E.G., Rudolph U. Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice. Neuropharmacology 2012, 63:250-258.
368. Sousa N., Almeida O.F., Wotjak C.T. A hitchhiker's guide to behavioral analysis in laboratory rodents. Genes Brain Behav 2006, 5:5-24.
369. Spasojević N., Gavrilović L., Varagić V.V., Dronjak S. Effects of chronic diazepam treatments on behavior on individually housed rats. Arch Biol Sci Belgrade 2007, 59:113-117.
370. Spielberger C.D., Gorsuch R.L., Lushene R.E. The State-Trait Anxiety Inventory: test manual 1970, Consulting Psychologist Press, Palo Alto, CA.
371. Spielberger C.D. Conceptual and methodological issues in anxiety research. Anxiety Curr Trends Theory Res 1972, 2:481-493.
372. Spooren W., Lesage A., Lavreysen H., Gasparini F., Steckler T. Metabotropic glutamate receptors: their therapeutic potential in anxiety. Curr Top Behav Neurosci 2010, 2:391-413.
373. Spruijt B.M., van Hooff J.A., Gispen W.H. Ethology and neurobiology of grooming behavior. Physiol Rev 1992, 72:825-852.
374. Stachowicz K., Klodzinska A., Palucha-Poniewiera A., Schann S., Neuville P., Pilc A. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems. Neuropharmacology 2009, 57:227-234.
375. Stapinski L.A., Abbott M.J., Rapee R.M. Evaluating the cognitive avoidance model of generalised anxiety disorder: impact of worry on threat appraisal, perceived control and anxious arousal. Behav Res Ther 2010, 48:1032-1040.
376. Steckler T. Developing small molecule nonpeptidergic drugs for the treatment of anxiety disorders: is the challenge still ahead?. Curr Top Behav Neurosci 2010, 2:415-428.
377. Steenbergen H.L., Farabollini F., Heinsbroek R.P.W., Van de Poll N.E. Sex-dependent effects of aversive stimulation on holeboard and elevated plus-maze behavior. Physiol Behav 1990, 48:571-576.
378. Steimer T. The biology of fear- and anxiety-related behaviors. Dialogues Clin Neurosci 2002, 4:231-249.
379. Strongman K.T. The effect of anxiety on food intake in the rat. Q J Exp Psychol 1965, 255-260.
380. Sziray N., Kuki Z., Nagy K.M., Markó B., Kompagne H., Lévay G. Effects of single and simultaneous lesions of serotonergic and noradrenergic pathways on open-space and bright-space anxiety-like behavior in two animal models. Behav Brain Res 2010, 209:93-98.
381. Takahashi L.K. Role of CRF1 and CRF2 receptors in fear and anxiety. Neurosci Biobehav Rev 2001, 25:627-636.
382. Takahashi L.K., Nakashima B.R., Hong H., Watanabe K. The smell of danger: a behavioral and neural analysis of predator odor-induced fear. Neurosci Biobehav Rev 2005, 29:1157-1167.
383. Täuber M., Calame-Droz E., Prut L., Rudolph U., Crestani F. Alpha2-gamma-aminobutyric acid (GABA)A receptors are the molecular substrates mediating precipitation of narcosis but not of sedation by the combined use of diazepam and alcohol in vivo. Eur J Neurosci 2003, 18:2599-2604.
384. Thiel C.M., Muller C.P., Huston J.P., Schwarting R.K. High versus low reactivity to a novel environment: behavioural, pharmacological and neurochemical assessments. Neuroscience 1999, 93:243-251.
385. Thiessen D.D., Graham M., Perkins J., Marcks S. Temperature regulation and social grooming in the Mongolian gerbil (Meriones unguiculatus). Behav Biol 1977, 19:279-288.
386. Thompson W.R. Influence of prenatal maternal anxiety on emotionality in young rats. Science 1957, 125:698-699.
387. Thorsell A. Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety. Exp Biol Med (Maywood) 2010, 235:1163-1167.
388. Ting J.T., Feng G. Neurobiology of obsessive-compulsive disorder: insights into neural circuitry dysfunction through mouse genetics. Curr Opin Neurobiol 2011, 21:842-848.
389. Torres A.A. Anxiety versus escape conditioning and tranquilizing action. J Comp Physiol Psychol 1961, 54:349-353.
390. Treit D., Menard J., Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 1993, 44:463-469.
391. Treit D., Engin E., McEown K. Animal models of anxiety and anxiolytic drug action. Curr Top Behav Neurosci 2010, 2:121-160.
392. Trent N.L., Menard J.L. The ventral hippocampus and the lateral septum work in tandem to regulate rats' open-arm exploration in the elevated plus-maze. Physiol Behav 2010, 101:141-152.
393. Troelsen K.B., Nielsen E.Ø., Mirza N.R. Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter. Psychopharmacology (Berl) 2005, 181:741-750.
394. Troisi A., Schino G. Environmental and social influences on autogrooming behaviour in a captive group of Java monkeys. Behaviour 1987, 100:292-302.
395. Van der Poel A.M. A note on "stretched attention", a behavioural element indicative of an approach-avoidance conflict in rats. Anim Behav 1979, 27:446-450.
396. van Erp A.M., Kruk M.R., Meelis W., Willekens-Bramer D.C. Effect of environmental stressors on time course, variability and form of self-grooming in the rat: handling, social contact, defeat, novelty, restraint and fur moistening. Behav Brain Res 1994, 65:47-55.
397. van Gaalen M.M., Steckler T. Behavioural analysis of four mouse strains in an anxiety test battery. Behav Brain Res 2000, 115:95-106.
398. van Rijnsoever C., Täuber M., Choulli M.K., Keist R., Rudolph U., Mohler H., et al. Requirement of alpha5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice. J Neurosci 2004, 24:6785-6790.
399. Varty G.B., Morgan C.A., Cohen-Williams M.E., Coffin V.L., Carey G.J. The gerbil elevated plus-maze I: behavioral characterization and pharmacological validation. Neuropsychopharmacology 2002, 27:357-370.
400. Vinkers C.H., van Oorschot R., Korte S.M., Olivier B., Groenink L. 5-HT1A receptor blockade reverses GABA(A) receptor alpha3 subunit-mediated anxiolytic effects on stress-induced hyperthermia. Psychopharmacology (Berl) 2010, 211:123-130.
401. Vikar V., Kks S., Vasar E., Rauvala H. Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiol Behav 2001, 72:271-281.
402. Vyas A., Chattarji S. Modulation of different states of anxiety-like behavior by chronic stress. Behav Neurosci 2004, 118:1450-1454.
403. Wahlsten D., Metten P., Phillips T.J., Boehm S.L., Burkhart-Kasch S., Dorow J., et al. Different data from different labs: lessons from studies of gene-environment interaction. J Neurobiol 2003, 54:283-311.
404. Wahlsten D., Rustay N.R., Metten P., Crabbe J.C. In search of a better mouse test. Trends Neurosci 2003, 26:132-136.
405. Wallace K.J., Rosen J.B. Predator odor as an unconditioned fear stimulus in rats: elicitation of freezing by trimethylthiazoline, a component of fox feces. Behav Neurosci 2000, 114:912-922.
406. Walsh R.N., Cummins R.A. The open-field test: a critical review. Psychol Bull 1976, 83:482-504.
407. Wang X., McCoy P.A., Rodriguiz R.M., Pan Y., Je H.S., Roberts A.C., et al. Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum Mol Genet 2011, 20:3093-3108.
408. Watt M.J., Burke A.R., Renner K.J., Forster G.L. Adolescent male rats exposed to social defeat exhibit altered anxiety behavior and limbic monoamines as adults. Behav Neurosci 2009, 123:564-576.
409. Wei Q., Lu X.Y., Liu L., Schafer G., Shieh K.R., Burke S., et al. Glucocorticoid receptor overexpression in forebrain: a mouse model of increased emotional lability. Proc Natl Acad Sci U S A 2004, 101:11851-11856.
410. Weiss S.M., Wadsworth G., Fletcher A., Dourish C.T. Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety. Neurosci Biobehav Rev 1998, 23:265-271.
411. Weisstaub N.V., Zhou M., Lira A., Lambe E., González-Maeso J., Hornung J.P., et al. Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 2006, 313:536-540.
412. Welch J.M., Lu J., Rodriguiz R.M., Trotta N.C., Peca J., Ding J.D., et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 2007, 448:894-900.
413. Welker W.I. "Free" versus "forced" exploration of a novel situation by rats. Psychol Rep 1957, 3:95-108.
414. Welker W.I. Escape, exploratory, and food-seeking responses of rats in novel situation. J Comp Physiol Psychol 1959, 52:106-111.
415. Whishaw I.Q., Gharbawie O.A., Benjamin J.C., Lehmann H. The exploratory behavior of rats in an open environment optimizes security. Behav Brain Res 2006, 171:230-239.
416. Wieronska J.M., Stachowicz K., Nowak G., Pilc A. The loss of glutamate-GABA harmony in anxiety disorders. Anxiety disorders 2011, 135-158. [chapter 8]. V. Kalinin (Ed.).
417. Wiltgen B.J., Godsil B.P., Peng Z., Saab F., June H.L., Linn M.L., et al. The alpha1 subunit of the GABA(A) receptor modulates fear learning and plasticity in the lateral amygdala. Front Behav Neurosci 2009, 3:37.
418. Wolff J.O., Watson M.W., Thomas S.A. Is self-grooming by male prairie voles a predictor of mate choice?. Ethology 2002, 108:169-179.
419. Yang M., Augustsson H., Markham C.M., Hubbard D.T., Webster D., Wall P.M., et al. The rat exposure test: a model of mouse defensive behaviors. Physiol Behav 2004, 81:465-473.
420. Yang M., Zhodzishsky V., Crawley J.N. Social deficits in BTBR T+tf/J mice are unchanged by cross-fostering with C57BL/6J mothers. Int J Dev Neurosci 2007, 25:515-521.
421. Yang M., Clarke A.M., Crawley J.N. Postnatal lesion evidence against a primary role for the corpus callosum in mouse sociability. Eur J Neurosci 2009, 29:1663-1677.
422. Yang X.W., Lu X.H. Molecular and cellular basis of obsessive-compulsive disorder-like behaviors: emerging view from mouse models. Curr Opin Neurol 2011, 24:114-118.
423. Yerkes R.M. Genetic aspects of grooming, a socially important primate behaviour pattern. J Soc Psychol 1933, 4:3-25.
424. Yokoyama F., Yamauchi M., Oyama M., Okuma K., Onozawa K., Nagayama T., et al. Anxiolytic-like profiles of histamine H3 receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic. Psychopharmacology (Berl) 2009, 205:177-187.
425. Zangrossi H., File S.E. Chlordiazepoxide reduces the generalised anxiety, but not the direct responses, of rats exposed to cat odor. Pharmacol Biochem Behav 1992, 43:1195-1200.
426. Zangrossi H., File S.E. Behavioral consequences in animal tests of anxiety and exploration of exposure to cat odor. Brain Res Bull 1992, 29:381-388.
427. Zarrindast M.R., Moghadam A.H., Rostami P., Roohbakhsh A. The effects of histaminergic agents in the central amygdala of rats in the elevated plus-maze test of anxiety. Behav Pharmacol 2005, 16:643-649.
428. Zinbarg R.E. Concordance and synchrony in measures of anxiety and panic reconsidered: A hierarchical model of anxiety and panic. Behav Ther 1998, 29:301-323.
429. Zuckerman M. Psychobiology of personality 1991, Cambridge University Press, Cambridge, UK.
430. Zvolensky M.J., Lejuez C.W., Eifert G.H. Prediction and control: operational definitions for the experimental analysis of anxiety. Behav Res Ther 2000, 38:653-663.